1452561-66-8

Basic information

• Product Name: 5-(trans-3-(benzyloxy)cyclobutyl)-7,7-dimethyl-5H-pyrrolo[2,3-b]pyrazin-6(7H)-one
• Synonyms: 5-(trans-3-(benzyloxy)cyclobutyl)-7,7-dimethyl-5H-pyrrolo[2,3-b]pyrazin-6(7H)-one
• CAS NO: 1452561-66-8
• Molecular Weight: 323.395
• Mol File: 1452561-66-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 5-(trans-3-(benzyloxy)cyclobutyl)-7,7-dimethyl-5H-pyrrolo[2,3-b]pyrazin-6(7H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(trans-3-(benzyloxy)cyclobutyl)-7,7-dimethyl-5H-pyrrolo[2,3-b]pyrazin-6(7H)-one(1452561-66-8)
• EPA Substance Registry System: 5-(trans-3-(benzyloxy)cyclobutyl)-7,7-dimethyl-5H-pyrrolo[2,3-b]pyrazin-6(7H)-one(1452561-66-8)

Safety Data

• Hazardous Substances Data: 1452561-66-8(Hazardous Substances Data)

Upstream product

• 1452561-64-6 2-(3-chloropyrazin-2-yl)-2-methylpropanoic acid 
• 92146-77-5 3-amino-1-benzyloxycyclobutane 

Relevant articles and documents

HETEROBICYCLIC COMPOUNDS

Heterobicyclic compounds of Formula (I): or a pharmaceutically-acceptable salt, tautomer, or stereoisomer thereof, as defined in the specification, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, Huntington's Disease, and the like.